Pembrolizumab [Keytruda] Decision, (201748044868)
No Annotations
Alert me when there are new annotations for this document
10 similar patent office decisions
-
Pembrolizumab [KEYTRUDA] decision, (201617025251)
Countries: India Date: 2024
-
Glecaprevir decision, (2981/DELNP/2013)
Countries: India Date: 2024
-
Sofosbuvir/Velpatasvir decision, (201627008488)
Countries: India Date: 2024
-
Bedaquiline decision, (201727030045)
Countries: India Date: 2024
-
Dolutegravir decision, (3865/KOLNP/2007)
Countries: India Date: 2024
-
Bedaquiline decision, (202017005443)
Countries: India Date: 2024
-
Quabodepistat (OPC-167832) decision, (201737004817)
Countries: India Date: 2024
-
imatinib (ITB) decision, (1602/MAS/98 )
Countries: India Date: 2006
-
sunitinib (su) decision, (IN/PCT/2002/00785/DEL )
Countries: India Date: 2012
-
Paclitaxel decision, (2899/DELNP/2005)
Countries: India Date: 2014